NASDAQ:ELAN - Elanco Animal Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$32.74 +0.14 (+0.43 %)
(As of 03/26/2019 04:00 PM ET)
Previous Close$32.60
Today's Range$32.51 - $33.14
52-Week Range$28.00 - $37.61
Volume4.00 million shs
Average Volume10.24 million shs
Market Capitalization$11.97 billion
P/E RatioN/A
Dividend YieldN/A
There is no company description available for Elanco Animal Health Inc.

Receive ELAN News and Ratings via Email

Sign-up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry --
Current SymbolNASDAQ:ELAN



Sales & Book Value

Annual SalesN/A



Market Cap$11.97 billion
Next Earnings Date5/1/2019 (Estimated)

Elanco Animal Health (NASDAQ:ELAN) Frequently Asked Questions

What is Elanco Animal Health's stock symbol?

Elanco Animal Health trades on the NASDAQ under the ticker symbol "ELAN."

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health (NASDAQ:ELAN) announced its quarterly earnings results on Wednesday, February, 6th. The company reported $0.29 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.26 by $0.03. The business earned $799.30 million during the quarter, compared to analyst estimates of $804.07 million. The business's revenue for the quarter was up 6.0% on a year-over-year basis. During the same period last year, the company earned $0.12 EPS. View Elanco Animal Health's Earnings History.

When is Elanco Animal Health's next earnings date?

Elanco Animal Health is scheduled to release their next quarterly earnings announcement on Wednesday, May 1st 2019. View Earnings Estimates for Elanco Animal Health.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health issued an update on its FY19 earnings guidance on Wednesday, February, 6th. The company provided earnings per share (EPS) guidance of $1.02-1.12 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.10. The company issued revenue guidance of $3.1-3.16 billion, compared to the consensus revenue estimate of $3.15 billion.Elanco Animal Health also updated its FY 2019 guidance to $1.02-1.12 EPS.

What price target have analysts set for ELAN?

13 equities research analysts have issued 1 year price targets for Elanco Animal Health's shares. Their predictions range from $28.00 to $38.00. On average, they anticipate Elanco Animal Health's stock price to reach $32.8782 in the next twelve months. This suggests a possible upside of 0.4% from the stock's current price. View Analyst Price Targets for Elanco Animal Health.

What is the consensus analysts' recommendation for Elanco Animal Health?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last year. There are currently 1 sell rating, 6 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Elanco Animal Health.

Has Elanco Animal Health been receiving favorable news coverage?

News coverage about ELAN stock has been trending negative recently, InfoTrie reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Elanco Animal Health earned a media sentiment score of -2.1 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the stock's share price in the near term.

Are investors shorting Elanco Animal Health?

Elanco Animal Health saw a increase in short interest in March. As of March 15th, there was short interest totalling 59,981,423 shares, an increase of 10.7% from the February 28th total of 54,173,571 shares. Based on an average trading volume of 27,072,420 shares, the days-to-cover ratio is currently 2.2 days. Currently, 16.4% of the shares of the stock are sold short. View Elanco Animal Health's Current Options Chain.

Who are some of Elanco Animal Health's key competitors?

What other stocks do shareholders of Elanco Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elanco Animal Health investors own include NVIDIA (NVDA), Walt Disney (DIS), Bank of America (BAC), Nucor (NUE), Amgen (AMGN), Alibaba Group (BABA), Oracle (ORCL), Exxon Mobil (XOM), Magellan Midstream Partners (MMP) and Alphabet (GOOG).

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an initial public offering on Thursday, September 20th 2018. The company issued 62,900,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

When did Elanco Animal Health's lock-up period expire?

Elanco Animal Health's lock-up period expired on Tuesday, March 19th. Elanco Animal Health had issued 62,900,000 shares in its public offering on September 20th. The total size of the offering was $1,509,600,000 based on an initial share price of $24.00. Shares of the company owned by major shareholders and company insiders are now eligible to be traded as a result of the end of the lock-up period.

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Amundi Pioneer Asset Management Inc. (1.58%), FMR LLC (1.21%), Massachusetts Financial Services Co. MA (0.96%), BlackRock Inc. (0.74%), American Century Companies Inc. (0.57%) and Norges Bank (0.53%). Company insiders that own Elanco Animal Health stock include Jeffrey N Simmons, Lawrence Erik Kurzius, R David Hoover and Ramiro Martin Cabral. View Institutional Ownership Trends for Elanco Animal Health.

Which institutional investors are selling Elanco Animal Health stock?

ELAN stock was sold by a variety of institutional investors in the last quarter, including Jane Street Group LLC, Bank of Montreal Can, Janney Montgomery Scott LLC, Principal Financial Group Inc., Picton Mahoney Asset Management, Daiwa Securities Group Inc. and BB&T Securities LLC. View Insider Buying and Selling for Elanco Animal Health.

Which institutional investors are buying Elanco Animal Health stock?

ELAN stock was bought by a variety of institutional investors in the last quarter, including Amundi Pioneer Asset Management Inc., Massachusetts Financial Services Co. MA, Norges Bank, BlackRock Inc., American Century Companies Inc., FMR LLC, Menta Capital LLC and Geode Capital Management LLC. Company insiders that have bought Elanco Animal Health stock in the last two years include Jeffrey N Simmons, Lawrence Erik Kurzius, R David Hoover and Ramiro Martin Cabral. View Insider Buying and Selling for Elanco Animal Health.

How do I buy shares of Elanco Animal Health?

Shares of ELAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Elanco Animal Health's stock price today?

One share of ELAN stock can currently be purchased for approximately $32.74.

How big of a company is Elanco Animal Health?

Elanco Animal Health has a market capitalization of $11.97 billion.

MarketBeat Community Rating for Elanco Animal Health (NASDAQ ELAN)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  49 (Vote Outperform)
Underperform Votes:  68 (Vote Underperform)
Total Votes:  117
MarketBeat's community ratings are surveys of what our community members think about Elanco Animal Health and other stocks. Vote "Outperform" if you believe ELAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ELAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 3/26/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel